{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:38:35Z","timestamp":1787002715699,"version":"build-2736575974"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Marbel Life2020 of Regione Lazio"},{"name":"CrestOptics-IIT JointLab for Advanced Microscopy"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer's disease (AD) is the most common cause of dementia in the elderly. In the pathogenesis of AD a pivotal role is played by two neurotoxic proteins that aggregate and accumulate in the central nervous system: amyloid beta and hyper-phosphorylated tau. Accumulation of extracellular amyloid beta plaques and intracellular hyper-phosphorylated tau tangles, and consequent neuronal loss begins 10\u201315 years before any cognitive impairment. In addition to cognitive and behavioral deficits, sensorial abnormalities have been described in AD patients and in some AD transgenic mouse models. Retina can be considered a simple model of the brain, as some pathological changes and therapeutic strategies from the brain may be observed or applicable to the retina. Here we propose new retinal biomarkers that could anticipate the AD diagnosis and help the beginning and the follow-up of possible future treatments. We analyzed retinal tissue of triple-transgenic AD mouse model (3xTg-AD) for the presence of pathological hallmarks during disease progression. We found the presence of amyloid beta plaques, tau tangles, neurodegeneration, and astrogliosis in the retinal ganglion cell layer of 3xTg-AD mice, already at pre-symptomatic stage. Moreover, retinal microglia in pre-symptomatic mice showed a ramified, anti-inflammatory phenotype which, during disease progression, switches to a pro-inflammatory, less ramified one, becoming neurotoxic. We hypothesize retina as a window through which monitor AD-related neurodegeneration process.<\/jats:p>","DOI":"10.1038\/s41419-018-0740-5","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T05:21:32Z","timestamp":1528348892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":150,"title":["Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer\u2019s disease in the 3xTg-AD mouse model"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5502-6740","authenticated-orcid":false,"given":"Alfonso","family":"Grimaldi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Brighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6517-9107","authenticated-orcid":false,"given":"Giovanna","family":"Peruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Ragozzino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bonanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7504-8197","authenticated-orcid":false,"given":"Cristina","family":"Limatola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Ruocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Di Angelantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"key":"740_CR1","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3389\/fnins.2016.00536","volume":"10","author":"JK Lim","year":"2016","unstructured":"Lim, J. K. et al. The eye as a biomarker for Alzheimer\u2019s disease. Front. Neurosci. 10, 536 (2016).","journal-title":"Front. Neurosci."},{"key":"740_CR2","unstructured":"WHO. Dementia: a Public Health Priority (World Health Organization, Geneva, 2012)."},{"key":"740_CR3","first-page":"77sr1","volume":"3","author":"DM Holtzman","year":"2011","unstructured":"Holtzman, D. M., Morris, J. C. & Goate, A. M. Alzheimer\u2019s disease: the challenge of the second century. Sci. Transl. Med. 3, 77sr1 (2011). Review.","journal-title":"Sci. Transl. Med."},{"key":"740_CR4","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois, B. et al. Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol. 13, 614\u2013629 (2014).","journal-title":"Lancet Neurol."},{"key":"740_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7, 263\u2013269 (2011).","journal-title":"Alzheimers Dement."},{"key":"740_CR6","doi-asserted-by":"publisher","first-page":"a006213","DOI":"10.1101\/cshperspect.a006213","volume":"2","author":"KA Johnson","year":"2012","unstructured":"Johnson, K. A., Fox, N. C., Sperling, R. A. & Klunk, W. E. Brain imaging in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2, a006213 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"740_CR7","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S1474-4422(17)30159-X","volume":"16","author":"GB Frisoni","year":"2017","unstructured":"Frisoni, G. B. et al. Strategic roadmap for an early diagnosis of Alzheimer\u2019s disease based on biomarkers. Lancet Neurol. 16, 661\u2013676 (2017).","journal-title":"Lancet Neurol."},{"key":"740_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2217\/bmm.15.17","volume":"9","author":"IJ MacCormick","year":"2015","unstructured":"MacCormick, I. J., Czanner, G. & Faragher, B. Developing retinal biomarkers of neurological disease: an analytical perspective. Biomark. Med. 9, 691\u2013701 (2015). Erratum in Biomark. Med. 9, 937 (2015).","journal-title":"Biomark. Med."},{"key":"740_CR9","first-page":"62","volume":"10","author":"MF Mendez","year":"1990","unstructured":"Mendez, M. F., Tomsak, R. L. & Remler, B. Disorders of the visual system in Alzheimer\u2019s disease. J. Clin. Neuroophthalmol. 10, 62\u201369 (1990). Review.","journal-title":"J. Clin. Neuroophthalmol."},{"key":"740_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0197-4580(96)00009-7","volume":"17","author":"JC Blanks","year":"1996","unstructured":"Blanks, J. C. et al. Retinal pathology in Alzheimer\u2019s disease. II. Regional neuron loss and glial changes in GCL. Neurobiol. Aging 17, 385\u2013395 (1996).","journal-title":"Neurobiol. Aging"},{"key":"740_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1600-0420.1996.tb00090.x","volume":"74","author":"TR Hedges","year":"1996","unstructured":"Hedges, T. R. et al. Retinal nerve fiber layer abnormalities in Alzheimer\u2019s disease. Acta Ophthalmol. Scand. 74, 271\u2013275 (1996).","journal-title":"Acta Ophthalmol. Scand."},{"key":"740_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/156720510790274491","volume":"7","author":"L Guo","year":"2010","unstructured":"Guo, L., Duggan, J. & Cordeiro, M. F. Alzheimer\u2019s disease and retinal neurodegeneration. Curr. Alzheimer Res. 7, 3\u201314 (2010).","journal-title":"Curr. Alzheimer Res."},{"key":"740_CR13","doi-asserted-by":"publisher","first-page":"5136","DOI":"10.1167\/iovs.08-1849","volume":"49","author":"A Ning","year":"2008","unstructured":"Ning, A., Cui, J., To, E., Ashe, K. H. & Matsubara, J. Amyloid-beta deposits lead to retinal degeneration in a mouse model of Alzheimer disease. Invest. Ophthalmol. Vis. Sci. 49, 5136\u20135143 (2008).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"740_CR14","first-page":"1077","volume":"43","author":"SJ McKinnon","year":"2002","unstructured":"McKinnon, S. J. et al. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest. Ophthalmol. Vis. Sci. 43, 1077\u20131087 (2002).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"740_CR15","doi-asserted-by":"publisher","first-page":"13444","DOI":"10.1073\/pnas.0703707104","volume":"104","author":"L Guo","year":"2007","unstructured":"Guo, L. et al. Targeting amyloid-beta in glaucoma treatment. Proc. Natl Acad. Sci. USA 104, 13444\u201313449 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"740_CR16","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13024-017-0199-3","volume":"12","author":"M Chiasseu","year":"2017","unstructured":"Chiasseu, M. et al. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer\u2019s disease. Mol. Neurodegener. 12, 58 (2017).","journal-title":"Mol. Neurodegener."},{"key":"740_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.exer.2014.08.006","volume":"127","author":"MM Edwards","year":"2014","unstructured":"Edwards, M. M. et al. Retinal macroglia changes in a triple transgenic mouse model of Alzheimer\u2019s disease. Exp. Eye Res. 127, 252\u2013260 (2014).","journal-title":"Exp. Eye Res."},{"key":"740_CR18","doi-asserted-by":"publisher","first-page":"673090","DOI":"10.1155\/2015\/673090","volume":"2015","author":"MH Madeira","year":"2015","unstructured":"Madeira, M. H., Boia, R., Santos, P. F., Ambr\u00f3sio, A. F. & Santiago, A. R. Contribution of microglia mediated neuroinflammation to retinal degenerative diseases. Mediat. Inflamm. 2015, 673090 (2015).","journal-title":"Mediat. Inflamm."},{"key":"740_CR19","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fnagi.2017.00214","volume":"9","author":"AI Ramirez","year":"2017","unstructured":"Ramirez, A. I. et al. The role of microglia in retinal neurodegeneration: Alzheimer\u2019s disease, Parkinson, and Glaucoma. Front. Aging Neurosci. 9, 214 (2017).","journal-title":"Front. Aging Neurosci."},{"key":"740_CR20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1167\/iovs.08-2384","volume":"50","author":"SE Perez","year":"2009","unstructured":"Perez, S. E., Lumayag, S., Kovacs, B., Mufson, E. J. & Xu, S. Beta-amyloid deposition and functional impairment in the retina of the APPswe\/PS1DeltaE9 transgenic mouse model of Alzheimer\u2019s disease. Invest. Ophthalmol. Vis. Sci. 50, 793\u2013800 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"740_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo, S. et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409\u2013421 (2003).","journal-title":"Neuron"},{"key":"740_CR22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","volume":"45","author":"LM Billings","year":"2005","unstructured":"Billings, L. M., Oddo, S., Green, K. N., McGaugh, J. L. & LaFerla, F. M. Intraneuronal Abeta causes the onset of early Alzheimer\u2019s disease-related cognitive deficits in transgenic mice. Neuron 45, 675\u2013688 (2005).","journal-title":"Neuron"},{"key":"740_CR23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.nbd.2014.11.013","volume":"81","author":"E Isopi","year":"2015","unstructured":"Isopi, E. et al. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer\u2019s disease without reducing amyloid and tau pathology. Neurobiol. Dis. 81, 214\u2013224 (2015).","journal-title":"Neurobiol. Dis."},{"key":"740_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.73","volume":"7","author":"A Grimaldi","year":"2016","unstructured":"Grimaldi, A. et al. KCa3.1 inhibition switches the phenotype of glioma-infiltrating microglia\/macrophages. Cell Death Dis. 7, e2174 (2016).","journal-title":"Cell Death Dis."},{"key":"740_CR25","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.2353\/ajpath.2008.080434","volume":"173","author":"N Louneva","year":"2008","unstructured":"Louneva, N. et al. Caspase-3 is enriched in postsynaptic densities and increased in Alzheimer\u2019s disease. Am. J. Pathol. 173, 1488\u20131495 (2008).","journal-title":"Am. J. Pathol."},{"key":"740_CR26","doi-asserted-by":"crossref","unstructured":"Eimer, W. A. & Vassar, R. Neuron loss in the 5XFAD mouse model of Alzheimer\u2019s disease correlates with intraneuronal A\u03b242 accumulation and Caspase-3 activation. Mol. Neurodegener. 8, 2 (2013).","DOI":"10.1186\/1750-1326-8-2"},{"key":"740_CR27","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00401-009-0539-7","volume":"117","author":"H Breyhan","year":"2009","unstructured":"Breyhan, H. et al. APP\/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy. Acta Neuropathol. 117, 677\u2013685 (2009).","journal-title":"Acta Neuropathol."},{"key":"740_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40478-015-0203-5","volume":"3","author":"IR Holtman","year":"2015","unstructured":"Holtman, I. R. et al. Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathol. Commun. 3, 31 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"740_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-3-27","volume":"3","author":"CA Colton","year":"2006","unstructured":"Colton, C. A. et al. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J. Neuroinflamm. 3, 27 (2006).","journal-title":"J. Neuroinflamm."},{"key":"740_CR30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/187152710791012071","volume":"9","author":"S Mandrekar-Colucci","year":"2010","unstructured":"Mandrekar-Colucci, S. & Landreth, G. E. Microglia and inflammation in Alzheimer\u2019s disease. CNS Neurol. Disord. Drug Targets 9, 156\u2013167 (2010).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"740_CR31","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290.e17 (2017).","journal-title":"Cell"},{"key":"740_CR32","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s00417-009-1060-3","volume":"247","author":"RM Dutescu","year":"2009","unstructured":"Dutescu, R. M. et al. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer\u2019s disease. Graefes. Arch. Clin. Exp. Ophthalmol. 247, 1213\u20131221 (2009).","journal-title":"Graefes. Arch. Clin. Exp. Ophthalmol."},{"key":"740_CR33","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.2353\/ajpath.2009.090159","volume":"175","author":"B Liu","year":"2009","unstructured":"Liu, B. et al. Amyloid-peptide vaccinations reduce {beta}-amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer\u2019s transgenic mice. Am. J. Pathol. 175, 2099\u20132110 (2009). Erratum in Am. J. Pathol. 176, 2055.","journal-title":"Am. J. Pathol."},{"key":"740_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.neurobiolaging.2009.03.002","volume":"32","author":"L Gasparini","year":"2011","unstructured":"Gasparini, L. et al. Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability. Neurobiol. Aging 32, 419\u2013433 (2011).","journal-title":"Neurobiol. Aging"},{"key":"740_CR35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/glia.20967","volume":"58","author":"M Olabarria","year":"2010","unstructured":"Olabarria, M., Noristani, H. N., Verkhratsky, A. & Rodr\u00edguez, J. J. Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer\u2019s disease. Glia 58, 831\u2013838 (2010).","journal-title":"Glia"},{"key":"740_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-120","volume":"8","author":"F Fischer","year":"2011","unstructured":"Fischer, F., Martin, G. & Agostini, H. T. Activation of retinal microglia rather than microglial cell density correlates with retinal neovascularization in the mouse model of oxygen-induced retinopathy. J. Neuroinflamm. 8, 120 (2011).","journal-title":"J. Neuroinflamm."},{"key":"740_CR37","doi-asserted-by":"publisher","first-page":"93621","DOI":"10.1172\/jci.insight.93621","volume":"2","author":"Y Koronyo","year":"2017","unstructured":"Koronyo, Y. et al. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight 2, 93621 (2017).","journal-title":"JCI Insight"},{"key":"740_CR38","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4103\/1673-5374.205083","volume":"12","author":"SA Lynn","year":"2017","unstructured":"Lynn, S. A. et al. The complexities underlying age-related macular degeneration: could amyloid beta play an important role? Neural Regen. Res. 12, 538\u2013548 (2017).","journal-title":"Neural Regen. Res."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0740-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0740-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0740-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T05:54:48Z","timestamp":1720331688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0740-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,6]]}},"alternative-id":["740"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0740-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"9 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"685"}}